Literature DB >> 20864305

Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients.

C Fotopoulou1, R Richter, E I Braicu, S-C Schmidt, W Lichtenegger, J Sehouli.   

Abstract

BACKGROUND: Postoperative tumor-residual-mass is the most important prognostic factor in epithelial ovarian cancer (EOC). Aim of our study was to define risk factors for incomplete tumor resection in advanced primary EOC. PATIENTS &
METHODS: A validated intraoperative documentation tool ("Intraoperative-Mapping of Ovarian-Cancer" = "IMO") was applied to systematically evaluate intraabdominal tumor dissemination pattern, maximal tumor load, tumor residuals and operative morbidity for all EOC-patients who underwent primary surgery in our institution during 09/2000-08/2009. Univariate- and multivariate analysis were performed to identify independent risk factors of incomplete tumor resection and operative complications.
RESULTS: We evaluated 360 consecutive EOC-patients of FIGO-stage-III/IV. In 221(61%) patients a complete tumor resection could be obtained. In 50(14%) patients tumor residuals were <0.5 cm. Sixty (17%) patients developed a major (14%) complication. Multivariate analysis identified intestinal resection (OR:2.0; 95%CI:1.14-3.4; p = 0.01) and macroscopical tumor residuals (OR:0.5; 95%CI:0.2-1.2; p = 0.05) as independent predictors of major operative morbidity. Tumor dissemination pattern and maximal tumor load were significantly different between tumor-free and not-tumor-free operated patients, with less extrapelvic tumor involvement in the tumor-free group (p < 0.001). More than 4 IMO-fields of tumor involvement (OR:3.3; 95%CI:1.5-7.0; p = 0.002) were identified to be of predictive significance for incomplete tumor resection. FIGO-stage, histology, age, CA125-levels, bowel resection and ascites did not affect optimal tumor resectability.
CONCLUSIONS: Tumor expanding in multiple (>4) abdominal quadrants was the major negative predictors for complete tumor resection in primary EOC-patients. Bowel resection and macroscopical tumor residuals were of predictive value for a higher operative major morbidity. Identifying high-risk patients for suboptimal tumor resection and operative complications may improve surgical outcome in advanced primary EOC.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20864305     DOI: 10.1016/j.ejso.2010.09.008

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  11 in total

1.  Correlation of Pattern of Spread and Outcomes in Advanced Epithelial Ovarian Cancers.

Authors:  Amrutha Ramachandran; Anupama Rajanbabu; Kiran Gulabrao Bagul; Keechilat Pavithran; Dehannathparambil K Vijaykumar
Journal:  Indian J Surg Oncol       Date:  2017-02-02

2.  Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study.

Authors:  J Brian Szender; Tiffany Emmons; Sarah Belliotti; Danielle Dickson; Aalia Khan; Kayla Morrell; A N M Nazmul Khan; Kelly L Singel; Paul C Mayor; Kirsten B Moysich; Kunle Odunsi; Brahm H Segal; Kevin H Eng
Journal:  Gynecol Oncol       Date:  2017-06-16       Impact factor: 5.482

3.  Computer-assisted 3D bowel length measurement for quantitative laparoscopy.

Authors:  Martin Wagner; Benjamin Friedrich Berthold Mayer; Sebastian Bodenstedt; Katherine Stemmer; Arash Fereydooni; Stefanie Speidel; Rüdiger Dillmann; Felix Nickel; Lars Fischer; Hannes Götz Kenngott
Journal:  Surg Endosc       Date:  2018-03-05       Impact factor: 4.584

4.  Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma.

Authors:  David M Hyman; Kara C Long; Edward J Tanner; Rachel N Grisham; Angela G Arnold; Jasmine Bhatia; Mary F Phillips; David R Spriggs; Robert A Soslow; Noah D Kauff; Douglas A Levine
Journal:  Gynecol Oncol       Date:  2012-05-08       Impact factor: 5.482

Review 5.  Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review.

Authors:  J Borley; C Wilhelm-Benartzi; R Brown; S Ghaem-Maghami
Journal:  Br J Cancer       Date:  2012-08-30       Impact factor: 7.640

6.  Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers.

Authors:  E-I Braicu; J Sehouli; R Richter; K Pietzner; C Denkert; C Fotopoulou
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

7.  The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.

Authors:  Karina Biskup; Elena Iona Braicu; Jalid Sehouli; Rudolf Tauber; Véronique Blanchard
Journal:  Dis Markers       Date:  2014-08-12       Impact factor: 3.434

Review 8.  The role of surgery in advanced epithelial ovarian cancer.

Authors:  María Martín-Cameán; Elsa Delgado-Sánchez; Antonio Piñera; Maria Dolores Diestro; Javier De Santiago; Ignacio Zapardiel
Journal:  Ecancermedicalscience       Date:  2016-08-17

9.  GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012.

Authors:  A González Martín; A Redondo; M Jurado; A De Juan; I Romero; I Bover; J M Del Campo; A Cervantes; Y García; J A López-Guerrero; C Mendiola; J Palacios; M J Rubio; A Poveda Velasco
Journal:  Clin Transl Oncol       Date:  2013-03-07       Impact factor: 3.405

10.  Small Bowel PCI Score as a Prognostic Factor of Ovarian Cancer Patients Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), a Retrospective Analysis of 130 Patients.

Authors:  Christos Iavazzo; Alexandros Fotiou; Victoria Psomiadou; Sofia Lekka; Dimitrios Katsanos; John Spiliotis
Journal:  Indian J Surg Oncol       Date:  2021-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.